FINWIRES · TerminalLIVE
FINWIRES

周三欧洲股市走低,霍尔木兹海峡仍处于关闭状态。

-- 周三,欧洲股市走低,油价飙升,尽管特朗普总统无限期延长了与伊朗的停火协议,但由于霍尔木兹海峡仍然关闭。 斯托克欧洲指数下跌0.4%,德国DAX指数下跌0.3%,英国富时100指数下跌0.2%,法国CAC40指数下跌0.9%,瑞士市场指数下跌0.5%。 据彭博社报道,英国3月份年度消费者价格指数(CPI)上涨3.3%,高于2月份的3.0%,符合分析师预期。3月份CPI环比上涨0.7%,高于2月份的0.4%,也高于彭博社调查的分析师预期的0.6%。 企业新闻方面,据彭博社周二援引知情人士报道,T-Mobile的最大股东德国电信正在考虑与这家美国运营商进行全面合并,这将是史上规模最大的公开并购交易。 报道称,这家持有T-Mobile 53%股份的德国电信一直在考虑成立一家新的控股公司,以股票收购的方式收购两家公司的股份。 T-Mobile和德国电信均拒绝就此事向置评。 这家德国电信运营商的股价在法兰克福下跌了4.6%。 据彭博社周三援引知情人士报道,汇丰银行已将安联保险、第一生命保险集团和住友生命保险列入其新加坡保险业务的潜在买家名单。 据匿名消息人士向媒体透露,这些公司正与顾问合作,准备在未来几周内对汇丰人寿新加坡公司提出具有约束力的收购要约。消息人士还补充说,汇丰可能会寻求对该业务高达20亿美元的估值。 汇丰发言人告诉,该公司“拒绝就市场猜测置评”,并表示其汇丰人寿新加坡部门仍在进行战略评估。安联拒绝置评,而第一三共和住友保险则未立即回应置评请求。 这家英国银行的股价在伦敦下跌了0.5%。 路透社周三援引ASML首席执行官克里斯托夫·富凯的话报道称,ASML产能和生产效率的提升应该可以避免其像近年来那样成为芯片行业的瓶颈。 据报道,福凯周三在荷兰费尔德霍芬举行的芯片制造商ASML年度股东大会上表示:“客户很可能会转向其他供应商,甚至寻找我们技术的替代方案;我们过去就曾遇到过这种情况。” ASML股价在阿姆斯特丹上涨0.6%。 必和必拓集团周三表示,其第三财季铜产量同比下降7%至47.68万吨,而铁矿石产量同比增长2%至6210万吨。 该公司表示,预计2026财年铜产量仍为190万吨至200万吨,铁矿石产量为2.58亿吨至2.69亿吨。 这家矿业公司的股价在伦敦上涨超过2%。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF